388 related articles for article (PubMed ID: 34125319)
1. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.
Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C
Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319
[TBL] [Abstract][Full Text] [Related]
2. The microbiome and gynaecological cancer development, prevention and therapy.
Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
[TBL] [Abstract][Full Text] [Related]
3. The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.
Chalif J; Wang H; Spakowicz D; Quick A; Arthur EK; O'Malley D; Chambers LM
Int J Gynecol Cancer; 2023 Dec; ():. PubMed ID: 38088183
[TBL] [Abstract][Full Text] [Related]
4. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment.
Chase D; Goulder A; Zenhausern F; Monk B; Herbst-Kralovetz M
Gynecol Oncol; 2015 Jul; 138(1):190-200. PubMed ID: 25957158
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the power within: engineering the microbiome for enhanced gynecologic health.
Brennan C; Chan K; Kumar T; Maissy E; Brubaker L; Dothard MI; Gilbert JA; Gilbert KE; Lewis AL; Thackray VG; Zarrinpar A; Knight R
Reprod Fertil; 2024 Apr; 5(2):. PubMed ID: 38513356
[TBL] [Abstract][Full Text] [Related]
6. Diet and gut microbiome interactions in gynecologic cancer.
AlHilli MM; Bae-Jump V
Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758
[TBL] [Abstract][Full Text] [Related]
7. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.
Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW
Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962
[TBL] [Abstract][Full Text] [Related]
8. Microbes in gynecologic cancers: Causes or consequences and therapeutic potential.
Wahid M; Dar SA; Jawed A; Mandal RK; Akhter N; Khan S; Khan F; Jogaiah S; Rai AK; Rattan R
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1179-1189. PubMed ID: 34302959
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
McKenzie ND; Hong H; Ahmad S; Holloway RW
Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
[TBL] [Abstract][Full Text] [Related]
10. The impact of the female genital tract microbiome in women health and reproduction: a review.
Punzón-Jiménez P; Labarta E
J Assist Reprod Genet; 2021 Oct; 38(10):2519-2541. PubMed ID: 34110573
[TBL] [Abstract][Full Text] [Related]
11. Beyond the reproductive tract: gut microbiome and its influence on gynecological health.
Pérez-Prieto I; Rodríguez-Santisteban A; Altmäe S
Curr Opin Clin Nutr Metab Care; 2024 Jun; 36(3):134-147. PubMed ID: 38656809
[TBL] [Abstract][Full Text] [Related]
12. Pilot Study of Vaginal Microbiome Using QIIME 2™ in Women With Gynecologic Cancer Before and After Radiation Therapy.
Bai J; Jhaney I; Daniel G; Watkins Bruner D
Oncol Nurs Forum; 2019 Mar; 46(2):E48-E59. PubMed ID: 30767956
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Role of Human Gastrointestinal Microbiota in the Pathogenesis of Vaginal Infection and Cervical Cancer.
Wang J; Yang Z; Li W
J Environ Pathol Toxicol Oncol; 2020; 39(4):365-373. PubMed ID: 33389908
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
15. The female reproductive tract microbiotas, inflammation, and gynecological conditions.
Gholiof M; Adamson-De Luca E; Wessels JM
Front Reprod Health; 2022; 4():963752. PubMed ID: 36303679
[TBL] [Abstract][Full Text] [Related]
16. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.
Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914
[TBL] [Abstract][Full Text] [Related]
17. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections.
García-Peñarrubia P; Ruiz-Alcaraz AJ; Martínez-Esparza M; Marín P; Machado-Linde F
Hum Reprod Update; 2020 Feb; 26(2):214-246. PubMed ID: 32108227
[TBL] [Abstract][Full Text] [Related]
18. The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine.
Rizzo AE; Gordon JC; Berard AR; Burgener AD; Avril S
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34208337
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions.
Borella F; Carosso AR; Cosma S; Preti M; Collemi G; Cassoni P; Bertero L; Benedetto C
ACS Infect Dis; 2021 May; 7(5):987-1009. PubMed ID: 33848139
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.
Muls A; Andreyev J; Lalondrelle S; Taylor A; Norton C; Hart A
Int J Gynecol Cancer; 2017 Sep; 27(7):1550-1559. PubMed ID: 28590950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
